Table 6

Effect of intervention on the secondary outcomes intention-to-treat analysis (who had two different measurements at baseline and 12 months)

OutcomeTime pointControlInterventionCrude DiD (95% CI)Adjusted DiD (95% CI)*
nMean (SD)nMean (SD)
HDL cholesterolBaseline901.4 (0.4)1091.3 (0.4)RefRef
12-month follow-up431.3 (0.3)311.2 (0.4)0.02 (−0.09 to 0.14)0.04 (−0.08 to 0.16)
LDL cholesterolBaseline772.8 (0.9)1082.9 (0.8)RefRef
12-month follow-up252.9 (1.2)282.7 (0.7)−0.28 (−0.71 to 0.15)−0.26 (−0.67 to 0.15)
TriglycerideBaseline921.7 (0.8)1141.7 (0.8)RefRef
12-month follow-up461.7 (0.8)321.5 (0.8)−0.20 (−0.50 to 0.09)−0.22 (−0.52 to 0.09)
Total cholesterolBaseline934.9 (0.9)1154.9 (1.0)RefRef
12-month follow-up514.9 (1.2)334.6 (0.8)−0.32 (−0.65 to 0.01)−0.31 (−0.64 to 0.01)
Quality of life change (mean (SD))Baseline950.88 (0.12)1200.87 (0.12)RefRef
12-month follow-up720.87 (0.16)540.90 (0.11)0.04 (0.00 to 0.08)0.04 (0.00 to 0.08)
  • *Adjusted for age, gender and state.

  • DiD, difference-in-differences; HDL, high-density lipoprotein; LDL, low-density lipoprotein.